|
| Commodity | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 |
| Antisera & oth. blood fractions & modified immunological prods., whether or ... | $4,935,175,000 | $5,595,273,000 | $8,292,449,000 | $9,831,440,000 | $10,693,970,000 | $11,900,936,151 | $15,379,308,527 |
| Vaccines for human medicine | $335,625,000 | $519,644,000 | $1,030,760,000 | $1,138,906,000 | $879,413,000 | $1,543,083,631 | $1,069,275,070 |
| Human blood; animal blood prepd. for therapeutic/prophylactic/diagnostic us ... | $415,670,000 | $435,414,000 | $356,479,000 | $420,261,000 | $385,254,000 | $366,486,900 | $384,729,224 |
| Total | $5,686,470,000 | $6,550,331,000 | $9,679,688,000 | $11,390,607,000 | $11,958,637,000 | $13,810,506,682 | $16,833,312,821 |
|
|
